Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Skin Diseases

In: Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2006. Chapter 37.
Free Books & Documents
Review

Skin Diseases

Roderick Hay et al.
Free Books & Documents

Excerpt

In assigning health priorities, skin diseases are sometimes thought of, in planning terms, as small-time players in the global league of illness compared with diseases that cause significant mortality, such as HIV/AIDS, community-acquired pneumonias, and tuberculosis. However, skin problems are generally among the most common diseases seen in primary care settings in tropical areas, and in some regions where transmissible diseases such as tinea imbricata or onchocerciasis are endemic, they become the dominant presentation. For instance, the World Health Organization's 2001 report (Mathers 2006) on the global burden of disease indicated that skin diseases were associated with mortality rates of 20,000 in Sub-Saharan Africa in 2001. This burden was comparable to mortality rates attributed to meningitis, hepatitis B, obstructed labor, and rheumatic heart disease in the same region. Using a comparative assessment of disability-adjusted life years (DALYs) from the same report, the World Health Organization recorded an estimated total of 896,000 DALYs for the region in the same year, similar to that attributed to gout, endocrine disease, panic disorders, and war-related injuries. As noted later, those figures require confirmation by more detailed studies, and their practical application to health interventions needs to be tested.

PubMed Disclaimer

References

    1. Abdel-Rahman S. M., Nahata M. C., Powell D. A. Response to Initial Griseofulvin Therapy in Pediatric Patients with Tinea Capitis. Annals of Pharmacotherapy. 1997;31:406–10. - PubMed
    1. Asiedu K., Etuaful S. Socioeconomic Implications of Buruli Ulcer in Ghana: A Three-year Review. American Journal of Tropical Medicine & Hygiene. 1998;59:1015–22. - PubMed
    1. Barton L. L., Friedman A. D., Portilla M. G. Impetigo Contagiosa: A Comparison of Erythromycin and Dicloxacillin Therapy. Pediatric Dermatology. 1988;5:88–91. - PubMed
    1. Benton B. Economic Impact of Onchocerciasis Control through the African Programme for Onchocerciasis Control: An Overview. Annals of Tropical Medicine & Parasitology. 1998;92(Suppl 1):S33–39. - PubMed
    1. Breneman D. L. Use of Mupirocin Ointment in the Treatment of Secondarily Infected Dermatoses. Journal of the American Academy of Dermatology. 1990;22:886–92. - PubMed

LinkOut - more resources